Analysis of Medication Use in Peritoneal Dialysis Patients in Two Units

Grabe D.W. , Low C.L. , Bailie G.R. , Eisele G. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997; 47: 117–21.

Kaplan B. , Mason N.A. , Shimp L. , Ascione F. Chronic hemodialysis patients. Part I: Characterization and drug-related problems. Ann Pharmacother 1994; 28: 316–19.

Manley H.M. , McClaran M.L. , Overbay D.K. , Wright M.A. , Reid G.M. , Bender W.L. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 2003; 41: 386–93.

United States Renal Data System. USRDS 1998 annual data report. Medication use among dialysis patients in the DMMS. Am J Kidney Dis 1998; 32(Suppl 1): S60–8.

Johnson C.A. , McCarthy J. , Bailie G.R. , Deane J. , Smith S. Analysis of renal bone disease treatment in dialysis patients. Am J Kidney Dis 2002; 39: 1270–7.

National Kidney Foundation. Kidney Diseases Outcomes Quality Initiative Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. 2003. Available at: URL: http://www.kidney.org/professionals/kdoqi/guidelines_bone/index.htm

Abbott K.C. , Bakris G.L. What have we learned from the current trials? Med Clin North Am 2004; 88: 189–207.